The neural crest is a stem population critical for development of the vertebrate craniofacial skeleton and peripheral ganglia. Neural crest cells originate along the border between the neural plate and epidermis 1 , migrate extensively and generate numerous derivatives, including neurons and glia of the peripheral nervous system, melanocytes, bone and cartilage of the head skeleton 2 . Impaired neural crest development is associated with human defects, including cleft palate 3 . Classically, the neural crest has been thought to form by interactions at the border between neural and non-neural ectoderm or mesoderm [4] [5] [6] [7] , and defined factors such as bone morphogenetic proteins (BMPs) and Wnt proteins have been postulated as neural crest-inducers [8] [9] [10] [11] [12] [13] . Although competence to induce crest cells declines after stage 10 (ref. 14) , little is known about when neural crest induction begins in vivo. Here we report that neural crest induction is underway during gastrulation and well before proper neural plate appearance. We show that a restricted region of chick epiblast (stage 3-4) is specified to generate neural crest cells when explanted under non-inducing conditions. This region expresses the transcription factor Pax7 by stage 41 and later contributes to neural folds and migrating neural crest. In chicken embryos, Pax7 is required for neural crest formation in vivo, because blocking its translation inhibits expression of the neural crest markers Slug, Sox9, Sox10 and HNK-1. Our results indicate that neural crest specification initiates earlier than previously assumed, independently of mesodermal and neural tissues, and that Pax7 has a crucial function during neural crest development.
To investigate early events in chick neural crest formation, we analysed the expression of known neural crest markers at progressively earlier embryonic stages. Expression of the paired box transcription factor Pax7 (ref. 15) (Fig. 1a) correlates with the presumptive neural crest domain in gastrulating embryos and precedes known neural crest markers such as Slug 16 and SoxE 17 . Using in situ hybridization and immunostaining, the Pax7 expression domain first appears at stage 4þ as two bilaterally symmetric oblique bands lateral to Hensen's node, extending diagonally about 400 mm towards the primitive streak. At stage 4þ, Pax7 expression does not overlap with markers of presumptive epidermis (Gata2), neural plate (Sox2), ectodermal placode (Dlx5) or neural plate border (BMP4 and Msx1) [18] [19] [20] . As the neural plate forms, Pax7 expression partly overlaps the border (stage 5; Fig. 1c) , and from stage 6 onwards gradually shifts to superimpose on the neural folds (with the exception of forebrain that forms no neural crest) (Fig. 1a) . In contrast, the related Pax3 gene was expressed more caudally and medially 21 ( Fig. 1b) . Later, Pax7 is expressed by migrating neural crest cells at midbrain and hindbrain regions (Fig. 2a) . Focal injections of CM-DiI were used to test the fate of the presumptive Pax7 expression domain in stage 3-4 embryos. This region becomes incorporated into the dorsal neural folds (45/57) and, at stages of neural crest cell migration (17/17), into migrating neural crest cells 22, 23 (Fig. 2b) . We next examined whether the prospective Pax7 region is specified to generate neural crest cells, where 'specification' is defined as the ability to form neural crest in the absence of exogenous signals when placed in a neutral environment. Accordingly, a thin strip of epiblast tissue was dissected perpendicular to, and 250 mm caudal to, the most rostral extent of the primitive streak of stage 3-4 embryos. The lower layer (hypoblast/mesendoderm) was removed and the epiblast strip was cut into approximately 80-mm pieces and explanted onto collagen gels. Explants were numbered from 1 to 6, from most lateral to the primitive streak. Only medial explants (about 300 mm from the primitive streak) generated migratory neural crest cells (staining positively for HNK-1 and Pax7; HNK-1 þ Pax7 þ ) (n ¼ 60/69 stage 4 embryos (Fig. 2c) ; n ¼ 25/30 stage 3 embryos (Fig. 2d) ).
To determine whether these explants could generate proper neural crest derivatives, stage 3 explants incubated for 36 h as above were further cultured under conditions permissive for melanogenesis. After 8 days, medial explants but not adjacent epiblast formed melanocytes (8/9), a genuine neural crest derivative (Fig. 2e) , as well as neurons. These results indicate that the presumptive Pax7 domain is specified to form neural crest as early as stage 3, before overt Pax7 expression, without signals from surrounding tissues.
Present models of neural crest induction indicate that interactions between neural and non-neural ectoderm and/or mesoderm might be crucial to the generation of neural crest. If true, this predicts that neural, non-neural and/or mesodermal tissues should be present in medial explants that will express Pax7 and generate neural crest cells. However, definitive neural tissue does not appear until after stage 4þ, and it requires neural stabilizing signals emanating from the node and head mesoderm. We therefore examined whether node or mesodermal markers were present within Pax7-expressing medial explants. First we investigated Pax7 protein and mRNA expression on epiblast explants cultured for different durations. Strong Pax7 expression was found on medial epiblast explants as early as 10 h in culture (6/6; Fig. 2f ). To examine whether Pax7 expression depended on the presence of mesoderm, Brachyury and Tbx6L (important markers of the node and early mesoderm) were examined together with Pax7 at 10 h. Pax7 protein was detected in medial epiblast explants independent of Brachyury, whereas primitive streak-derived explants were Brachyury-positive (12/12; Fig. 2g ). Similarly, most medial epiblast explants expressed Pax7 protein (Fig. 2h ) or Pax7 mRNA ( Fig. 2i ) but failed to express Tbx6L mRNA (5/6 and 3/4 explants, respectively).
Expression of Pax7 independently of mesodermal and neural markers was confirmed on individual stage 3 epiblast explants cultured for 10 h using polymerase chain reaction with reverse transcription (RT-PCR) ( Supplementary Fig. 1 ). Explant sets derived from six embryos were analysed for multiple products in single reactions. Pax7, but not the mesodermal markers Brachyury or Slug (expressed in primitive streak at these early stages), was detected in medial explants. Instead, mesodermal markers were clearly detected in explants derived from primitive streak. Sox2 (a neural marker) was not detected in stage 3 epiblast explants cultured for 10 h even when derived from anterior regions fated to generate neural plate, but robust expression occurred in neural plate at stage 5 and whole embryos at stage 10. These findings confirm our in situ hybridization and immunostaining results and support a model for early neural crest formation-including Pax7 expression-independently of mesodermal and neural tissues.
As previous studies have implicated BMP and Wnt signals in neural crest induction, we implanted beads coated with Wnt or BMP inhibitors into the presumptive Pax7 expression domain. Embryos receiving beads coated with a Wnt inhibitor (Fz5) or with a BMP inhibitor (Noggin) showed a decrease in Pax7 expression (14/21 with Fz5; 8/10 with noggin), whereas control beads coated in bovine serum albumin (BSA) had no effect (13/13; Supplementary Table 1) . These results indicate that Wnt and BMP proteins might be required for neural crest induction during gastrulation.
To examine whether Pax7 is required for neural crest formation in vivo, we used antisense morpholino oligonucleotides (Pax7-mo) specifically to prevent the translation of Pax7 protein. We first showed that Pax7-mo reduced translation of Pax7 protein in vitro (Fig. 3a) . We then electroporated Pax7-mo unilaterally into the presumptive neural crest domain of stage 4 embryos in vivo; the contralateral side served as an internal control. Cells that inherited Pax7-mo showed a marked decrease in Pax7 protein levels (Fig. 3b) . Furthermore, significant decreases in the neural crest markers Slug (24/37 embryos), Sox9 (40/52) and Sox10 (36/55) were observed on the electroporated side of the embryos (Fig. 3f-h ). Downregulation of Slug and Sox9 in Pax7-mo-treated embryos was detected as early as stage 8, corresponding to 8-12 h after electroporation and when Slug and Sox9 are first detectable in the neural folds. In contrast, embryos electroporated with a five-mismatch control morpholino showed no obvious alterations in levels of Slug (1/31 embryos), Sox9 (1/45) or Sox10 (0/38) (Fig. 3c-e) . Cell viability as assessed by staining with 4 0 ,6-diamidino-2-phenylindole was unchanged in control and Pax7-mo-treated embryos (data not shown). To quantify the effects on neural crest markers, the intensity of expression was scored in identical boxed areas on control and treated sides of embryos that received Pax7-mo or control morpholinos. Sox9 expression was decreased by Pax7-mo to less than 40% of that on the contralateral side, but was unchanged in those receiving control morpholino (Fig. 3i) . In Pax7-mo-treated embryos allowed to develop to stages of cranial neural crest migration, there was a strong decrease in the number of Pax7 þ HNK1 þ migratory midbrain neural crest cells (4/4; Fig. 3j ). These results support an important role for Pax7 in neural crest formation during gastrulation or early neurulation that subsequently affects the migrating population. In contrast to our results for Pax7, we were unable to detect an early requirement for Pax3 using a morpholino against Pax3 (0/10 embryos showing changes in Slug expression, 1/9 for Sox9 and 2/9 for Sox10).
In 27 . Mouse Pax3 and Pax7 expression have been reported to initiate after formation of the neural plate and neural folds at embryonic day (E)8.5 (refs 24, 25) . We therefore examined their expression ( Supplementary Fig. 2 ), and found low levels of Pax3 and Pax7 in distinct patterns in the epiblast at E6.5. Specifically, we found nuclear Pax7 in the embryonic ectoderm (future neurectoderm) and in the neuroepithelium of the future headfold. Nuclear Pax3 and Pax7 were detected in anterior neural fold cells by E7.5. Caudal neural folds containing the most recently formed prospective neural crest express only Pax7. These data raise the possibility that the mechanisms we describe for birds might be common to amniotes and perhaps all vertebrates. Consistent with this possibility is the observation that knockdown of Pax3 in Xenopus alters neural crest induction 28 . Neural crest cells are derived from ectoderm, and were thought to originate by means of interactions between neural and non-neural 
Pax7
þ migratory crest cells. e, Explants cultured for 8 additional days under conditions permissive for melanogenesis contain melanocytes in medial epiblast explants (top left and bottom) but not from adjacent regions (top right). f-i, Explants from stage 3 embryos. f, Nuclear expression of Pax7 (red) from stage 3 explants is only seen in medial regions after 10 h (explant 2). g, Immunostaining for Brachyury (green) and Pax7 (red) expression in stage 3 explants after a 10-h incubation shows no colocalization of the two markers. Brachyury is restricted to primitive-streak-derived explants whereas Pax7 is seen in medial epiblast explants (explants 2-3). h, Combined whole-mount in situ hybridization for Tbx6L (top, blue), and immunofluorescence staining for Pax7 (bottom, red) performed on medial epiblast explants extracted from the collagen after 10 h of incubation. No overlap was observed in most (5/6) medial explants. Top left and middle panels show no overlap, expressing exclusively Pax7. Top right panel shows co-expression of Pax7 and Tbx6L. i, In situ hybridization for Tbx6L (blue) and Pax7 (red) in sections of medial epiblast explants cultured in collagen for 14 h. Top, a section containing one explant positive for Pax7 and one for Tbx6L. Bottom, higher-magnification images of three explants showing Pax7 (left), Tbx6L (middle) or no expression at all (right).
ectoderm and/or mesoderm 4 . Here we present the finding that discrete regions of epiblast from stage 3-4 chick embryos are already specified to form neural crest. The medial epiblast will express Pax7 and generate neural crest cells in isolation from other tissues. Neural induction is underway by stage 3 but requires later signals that emanate from the node and mesoderm to initiate neural fate 29 ; thus, our explants come from embryos without definitive neural tissue, such that neural tissue cannot account for neural crest formation.
Furthermore, we show that the medial epiblast is specified to form neural crest in the absence of definitive neural and early mesodermal markers. Thus, the mechanisms underlying the ability to recapitulate neural crest formation in vitro at neurula stages by juxtaposing neural tissue with non-neural ectoderm or mesoderm may be different from those functioning in vivo in the early gastrula. Our results indicate that formal establishment of a neural plate border might not be requisite for neural crest specification or induction, and that border formation and neural crest induction might be separable events. This is consistent with the observation that overexpression of Dlx5 creates an ectopic neural plate border but does not induce neural crest 30 . Together, these results indicate that all necessary components for generating neural crest cells might be present in the medial epiblast of gastrulating avian embryos.
Our results place the initiation of neural crest induction at or before gastrulation. We establish Pax7 as an early marker required for neural crest formation in avian embryos. In contrast with previous models, we find that neither mesoderm nor proper neural tissues are required for early neural crest induction.
METHODS
Details of in situ hybridization and immunohistochemistry, morpholino electroporation, in vitro translation, embryo dissection and tissue culture, and genes, primers and product sizes for RT-PCR are given in Supplementary Information. Middle and right panels show higher-magnification images of the region containing morphpolinos, showing the cells that received the morpholinos (middle), and the reduction in Pax7 levels in these same cells (right). c-h, Pax7-mo (f, g, h) downregulates expression of the neural crest markers Slug, Sox9 and Sox10 (black arrowheads), but control morpholinos (c, d, e) have no effect on their expression (arrowheads). Insets show the localization of morpholinos before in situ hybridization (red arrowheads). i, Quantitative analysis of the effects of control morpholinos (5 base-pair mismatch) and Pax7-mo on Sox9 expression compared to untreated neural fold (100%). Error bars show s.d. Neural folds electroporated with Pax7-mo show a 65% decrease in Sox9 transcript levels, and neural folds electroporated with control morpholinos show no significant difference in Sox9 expression compared to untreated neural folds. j, Midbrain section of a stage 10 embryo electroporated with mo-Pax7 (green), showing a reduction in Pax7 (red) and HNK-1 (blue, yellow arrow) levels on the electroporated side. The white arrow points to the normal HNK-1 staining on the untreated side.
